Pharmakon Advisors
14 portfolio companies · 6 on the map · $1.8B raised · 6 cities
Portfolio map
6 Pharmakon Advisors portfolio companies on the map.
Portfolio companies
Precigen
Germantown
Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.
Biotechnology Research$809.8MEst. 2020
UroGen Pharma
Princeton
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
Biotechnology Research$529.6MEst. 2004
Akebia Therapeutics
Cambridge
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Biotechnology Research$442.5MEst. 2007
Coherus Oncology
Redwood City
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Biotechnology ResearchPublicEst. 2010
Tarsus Pharmaceuticals
Irvine
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Pharmaceutical ManufacturingPublicEst. 2017Hiring fast
Depomed
Newark
Assertio develops and commercializes prescription pharmaceutical products focused on pain management and inflammation-related conditions.
Pharmaceutical ManufacturingPublicEst. 1995
More portfolio companies
8 more Pharmakon Advisors investments we track beyond the map.
Portfolio map
6 Pharmakon Advisors portfolio companies on the map.